skip to content

We are Roche

A healthier future. It’s what drives us to innovate.

To continuously advance science and ensure everyone has access to the healthcare they need today and for generations to come.

Creating a world where we all have more time with the people we love.

That’s what makes us Roche.

In the spotlight

Roche publishes its First Quarter Results for 2025

Roche continues with good momentum in 2025 with 6% (CER) sales growth in the first quarter. Commenting on the results, Roche CEO Thomas Schinecker said “We had a good start to the year with Group sales increasing and we achieved a number of important milestones.”

How we improved outcomes for patients around the world

Our efforts in Pharmaceuticals and Diagnostics have defined a year of remarkable achievement, focusing on preventing, stopping and curing diseases. Discover the highlights in our Annual Report.

For Investors

Reporting

Share and Bond information

Finance Information Tool

Discover great stories about
SciencePartnershipCulturePatientsSociety

Perspectives and powerful moments that shape healthcare.

Improving the patient journey

From diagnostics to therapeutics, Roche is innovating new options for people living with Alzheimer’s disease

We will prevent diseases by identifying high-risk patients early to enable timely use of medicines.

Our Strategy

We will stop diseases by accurately diagnosing and stratifying patients to halt disease progression through targeted medicines.

Our Diagnostics Solutions

We will cure diseases by identifying the cause of disease in order to restore health through curative medicines.

Our Pharma Solutions
Careers

Join us!

Learn more about exciting career opportunities at Roche, one of the world's leading research-based healthcare companies.

FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness

Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME)

Read more

Roche Accessibility Statement

At Roche, we are committed to ensuring that our websites and digital resources are accessible to all users.

Read more